


To achieve capital growth.
| Name | % Net Assets |
|---|---|
| Beximco Pharmaceuticals | 5.6% |
| Alliance Pharmaceuticals | 3.9% |
| Eckoh | 3.8% |
| Northern Petroleum | 3.6% |
| Velosi | 3.1% |
| RCG Holdings | 3.1% |
| Faroe Petroleum | 2.8% |
| Gulfsands Petroleum | 2.8% |
| Norman Hay | 2.7% |
| Tristel | 2.6% |
| Key | % Net Assets |
|---|---|
| 5.6% | |
| 3.9% | |
| 3.8% | |
| 3.6% | |
| 83.1% |
| Date | 15-Sep-2017 |
|---|---|
| NAV | 256.60p |
| Currency | GBP |
| Change | -1.30p |
| % | -0.50% |
| YTD change | 256.60p |
| YTD % | n/a |
| Fund Inception | 05/10/2005 |
|---|---|
| Fund Manager | Paul Mumford |
| TER | 1.64 (15-Nov-2011) |
| Minimum Investment | |
|---|---|
| Initial | £2500 |
| Additional | £1,500 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.02 |
You are here: research